FDA Inspection 1068898 — Human Genome Sciences Inc

Human Genome Sciences Inc — FEI 3003782237

The FDA completed an inspection of Human Genome Sciences Inc on August 30, 2018 in Rockville, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 30, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rockville, MD (United States)